Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-02-26

FDA Approved: ZONISAMIDE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for zonisamide from BluePoint Laboratories, signaling approval of changes to the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

SUPPL AP for ZONISAMIDE (ZONISAMIDE)